Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.
Subject: Epilepsy - PUBLISHED VIA Author Manuscript
Author(s):
Porter BE, Jacobson C
View Source >>
Related Studies:
Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe Epilepsy.
Published via Frontiers in Pharmacology
Cannabidiol: promise and pitfalls.
Published via Epilepsy Currents
Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.
Published via Journal of Pharmacology and Experimental Therapeutics
Cannabidiol Treatment for Refractory Seizures in Sturge-Weber Syndrome.
Published via Pediatric Neurology
The cannabinoids as potential antiepileptics.
Published via Journal of Clinical Pharmacology
Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
Published via Epilepsy & Behavior
Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors and Activates Hippocampal Cell Autophagy Pathway Along with Antioxidant Defense in Chronic Phase of Pilocarpine-Induced Seizure
Published via Journal of Molecular Neuroscience
Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures.
Published via European Journal of Epilepsy
Report from a Survey of Parents Regarding the Use of Cannabidiol (Medicinal cannabis) in Mexican Children with Refractory Epilepsy.
Published via Neurology Research International
Hypnotic and antiepileptic effects of cannabidiol.
Published via Journal of Clinical Pharmacology
Cannabidiol–antiepileptic drug comparisons and interactions in experimentally induced seizures in rats.
Published via Journal of Pharmacology and Experimental Therapeutics
Pharmacology of cannabinoids in the treatment of epilepsy.
Published via Epilepsy & Behavior
Chronic administration of cannabidiol to healthy volunteers and epileptic patients.
Published via Pharmacology
Endocannabinoid system protects against cryptogenic seizures.
Published via Pharmacological Reports
Seizing an opportunity for the endocannabinoid system.
Published via Epilepsy Currents
Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability
Published via ACS Chemical Neuroscience
Cannabinoids for epilepsy.
Published via Cochrane Database of Systematic Reviews
Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
Published via Author Manuscript
Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression
Published via PeerJ
Cannabis, cannabidiol, and epilepsy–from receptors to clinical response.
Published via Epilepsy & Behavior